NCT03643211View on ClinicalTrials.gov

Xeljanz Special Investigation for Long-term Use in UC Patients

CompletedOBSERVATIONAL
Enrollment

2,016

Participants

Timeline

Start Date

June 8, 2018

Primary Completion Date

November 10, 2022

Study Completion Date

November 10, 2022

Conditions
Ulcerative Colitis
Trial Locations (1)

Unknown

Pfizer Local Country Office, Tokyo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03643211 - Xeljanz Special Investigation for Long-term Use in UC Patients | Biotech Hunter | Biotech Hunter